ISIS PHARMACEUTICALS INC's ticker is ISIS and the CUSIP is 464330109.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $22,787,000 | +204.0% | 563,753 | +332.8% | 0.05% | +206.7% |
| Q2 2015 | $7,496,000 | -6.1% | 130,251 | +3.9% | 0.02% | -16.7% |
| Q1 2015 | $7,981,000 | +14.6% | 125,347 | +11.1% | 0.02% | +20.0% |
| Q4 2014 | $6,967,000 | +305.5% | 112,847 | +155.0% | 0.02% | +200.0% |
| Q3 2014 | $1,718,000 | -65.8% | 44,247 | -69.7% | 0.01% | -64.3% |
| Q2 2014 | $5,024,000 | +108.3% | 145,847 | +161.3% | 0.01% | +100.0% |
| Q1 2014 | $2,412,000 | -3.6% | 55,819 | -11.1% | 0.01% | 0.0% |
| Q4 2013 | $2,503,000 | +11.0% | 62,819 | +4.6% | 0.01% | -12.5% |
| Q3 2013 | $2,255,000 | +83.8% | 60,072 | +31.5% | 0.01% | +100.0% |
| Q2 2013 | $1,227,000 | +96.3% | 45,672 | -23.5% | 0.00% | +33.3% |
| Q4 2012 | $625,000 | – | 59,710 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 5,976,526 | $368,991,000 | 11.95% |
| HWG Holdings LP | 155,584 | $9,606,000 | 6.84% |
| DOWLING & YAHNKE LLC | 676,313 | $41,756,000 | 5.20% |
| Ghost Tree Capital, LLC | 150,000 | $9,261,000 | 4.44% |
| WILLIAM HARRIS INVESTORS INC | 276,870 | $17,094,000 | 4.41% |
| GRAYBILL WEALTH MANAGEMENT, LTD. | 61,225 | $3,780,000 | 2.87% |
| Opus Point Partners Management, LLC | 45,418 | $2,804,000 | 2.77% |
| PINNACLE ASSOCIATES LTD | 1,917,838 | $118,407,000 | 2.32% |
| Ghost Tree Capital, LLC | 50,000 | $3,087,000 | 1.48% |
| Adamant Biomedical Investments AG | 100,000 | $6,174,000 | 1.48% |